Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 4:05 pm | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $13.59 | $135,939 | 80,000 (Direct) | View |
| 2024-02-01 Purchase | 2024-02-05 5:02 pm | Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 2,481,350 | $12.09 | $29,999,522 | 6,485,420 (Indirect) | View |
| 2024-01-26 Sale | 2024-01-30 5:03 pm | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $11.14 | $111,364 | 189,200 (Direct) | View |
| 2023-12-21 Purchase | 2023-12-22 2:51 pm | Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 740,000 | $6.2 | $4,588,000 | 4,004,070 (Indirect) | View |
| 2023-10-16 Purchase | 2023-10-18 4:11 pm | Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 1,074,608 | $6.514 | $6,999,997 | 4,490,113 (Indirect) | View |
| 2022-12-19 Purchase | 2022-12-21 4:52 pm | Astria Therapeutics Inc. | ATXS | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 908,265 | $11.01 | $9,999,998 | 2,189,462 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-08 Option Award | 2024-04-09 08:11 am | N/A 2034-04-07 | Astria Therapeutics Inc. | ATXS | AGARWAL SUNIL Director | 28,200 | $0 | 28,200 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:05 pm | N/A 2032-07-31 | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $0 | 80,000 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:05 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $3.87 | 80,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:06 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:06 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President | 534,600 | $0 | 534,600 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 5:03 pm | N/A 2032-07-31 | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $0 | 189,200 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-30 5:03 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 10,000 | $3.87 | 189,200 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:08 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Milne Jill C. CEO and President | 275,000 | $0 | 275,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:08 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:07 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:07 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Harshbarger Benjamin Chief Legal Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:06 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:06 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:06 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | Violin Jonathan Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:05 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:04 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | Callori Fred Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:04 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:03 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Clauser Noah Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:02 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:00 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-19 08:10 am | N/A 2033-04-16 | Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2023-04-19 08:09 am | N/A 2024-08-26 | Astria Therapeutics Inc. | ATXS | Matthews Andrea Chief Business Officer | 0 | $0 | 171,431 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-02 08:51 am | N/A 2032-07-31 | Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:33 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:33 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:33 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Violin Jonathan Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:32 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Beck Joanne T. Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:32 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Cole Hugh M Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:32 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:31 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | Callori Fred Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-09 6:01 pm | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | KISHBAUCH MICHAEL D Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-09 6:00 pm | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 8,333 | $0 | 8,333 (Direct) | View |